Distinct Secretory Activity and Clinical Impact of Subcutaneous Abdominal Adipose Tissue in Women with Rheumatoid Arthritis and Osteoarthritis
- 282 Downloads
In the general population, low-grade inflammation of adipose tissue accompanies obesity and contributes to cardiovascular disease (CVD) development, but the implication of this tissue in rheumatic disease pathology is unclear. Therefore, we characterized the secretory activity of subcutaneous abdominal adipose tissue (SAAT) of females with rheumatoid arthritis (RA) and osteoarthritis (OA) and searched for its relationship with intensity of systemic inflammation, body composition and comorbidity. The secretion of classical adipokines (leptin, adiponectin), pro- and anti-inflammatory factors, i.e. interleukin (IL)-6, IL-8, IL-10, tumour necrosis factor (TNF), macrophage migration inhibitory factor (MIF) and hepatocyte growth factor (HGF), from SAAT explants was measured by specific enzyme-linked immunosorbent assays. Patients’ body composition was evaluated by bioelectric impendence technique. Rheumatoid SAAT secreted more adiponectin, IL-6, IL-10, TNF and MIF but less leptin than respective osteoarthritis tissues. In RA patients, TNF secretion correlated with cachectic body composition, HGF release was linked to secondary amyloidosis and visceral fat rating was an independent risk factor for CVD. In OA, secretion of leptin and HGF positively, while adiponectin inversely, correlated with systemic inflammation markers, and the release of MIF was an independent risk factor for CVD. This study reveals differences between RA and OA patients in SAAT secretory activity and suggests its different clinical impact in these diseases, characterized by high- and low-grade systemic inflammation, respectively. In RA, SAAT may directly or via an effect on body composition contribute to amyloidosis, cachexia or CVD co-occurring, while in OA SAAT-derived adipocytokines may rather regulate intensity of systemic inflammation and redound to CVD emergence.
KEY WORDSsubcutaneous abdominal adipose tissue activity osteoarthritis rheumatoid arthritis comorbidity systemic inflammation body composition
We gratefully acknowledge all patients for their contribution to the study and Iwona Janicka and Urszula Musiałowicz for outstanding technical assistance.
All authors have made substantial contributions to (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be submitted.
Compliance with Ethical Standards
All procedures involving human participants were performed in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of Interest
The authors declare that they have no conflicts of interests.
Informed consent was obtained from all individual participants included in the study.
This study was funded by the National Institute of Geriatrics, Rheumatology and Rehabilitation (grant number S/16), Warsaw, Poland. The National Institute of Geriatrics, Rheumatology and Rehabilitation is supported by a core grant from the Ministry of Science and Higher Education (Poland).
- 4.van Dijk, G.M., C. Veenhof, F. Schellevis, H. Hulsmans, J.P. Bakker, H. Arwent, J.H. Dekker, G.J. Lankhorst, and J. Dekker. 2008. Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskeletal Disorders 9: 95.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Kontny, E., M. Plebanczyk, B. Lisowska, M. Olszewska, P. Maldyk, and W. Maslinski. 2012. Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: contribution to adipocytokine network. Annals of the Rheumatic Diseases 71: 262–267.CrossRefPubMedGoogle Scholar
- 15.Eymard, F., A. Pigenet, D. Citadelle, C.H. Flouzat-Lachaniette, A. Poignard, C. Benelli, F. Berenbaum, X. Chevalier, and X. Houard. 2014. Induction of an inflammatory and prodegenerative phenotype in autologous fibroblast-like synoviocytes by the infrapatellar fat pad from patients with knee osteoarthritis. Arthritis and Rheumatology 66: 2165–2174.CrossRefPubMedGoogle Scholar
- 16.Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315–324.CrossRefPubMedGoogle Scholar
- 22.Šenolt, L., A. Kuklová, L.A. Cerezo, H. Hulejová, M. Filková, L. Bošanovská, O. Pecha, K. Pavelka, M. HaluzíK, and J. Vencovský. 2011. Adipokine profile is modulated in subcutaneous adipose tissue by TNFα inhibitors in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 70: 2054–2056.CrossRefPubMedGoogle Scholar
- 23.Toussirot, E., L. Mourot, B. Dehecq, D. Wendling, É. Grandclément, and G. Dumoulin. 2014. TNFα blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study. European Journal of Nutrition 53: 951–961.CrossRefPubMedGoogle Scholar
- 26.Adamopoulous, I.E., and N.A. Athanasou. 2006. Hepatocyte growth factor in normal and diseased bone and joint tissue. Current Rheumatology Reviews 2: 1–7.Google Scholar
- 28.Mirpourian, M., M. Salesi, H. Abdolahi, Z. Faraizadegan, and H. Karimzadeh. 2014. The association of body mass index with disease activity and clinical response to combinational therapy in patients with rheumatoid arthritis. Journal of Research in Medical Sciences 19: 509–514.PubMedPubMedCentralGoogle Scholar
- 29.Giles, J.T., M. Allison, R.S. Blumenthal, W. Post, A.C. Gelber, M. Petri, R. Tracy, M. Szklo, and J.M. Bathon. 2010. Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis and Rheumatism 62: 3173–3182.CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Grandaunet, B., S.W. Syversen, M. Hoff, A. Sundan, G. Haugeberg, D. van Der Heijde, T.K. Kvien, and T. Standal. 2011. Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis. Arthritis and Rheumatism 63: 662–669.CrossRefPubMedGoogle Scholar